N4 Pharma PLC
LSE:N4P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Kyland Technology Co Ltd
SZSE:300353
|
CN |
N4 Pharma PLC
EPS (Diluted)
N4 Pharma PLC
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
N4 Pharma PLC
LSE:N4P
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
EPS (Diluted)
£1
|
CAGR 3-Years
-28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-2%
|
|
|
AstraZeneca PLC
LSE:AZN
|
EPS (Diluted)
$6
|
CAGR 3-Years
46%
|
CAGR 5-Years
22%
|
CAGR 10-Years
11%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
EPS (Diluted)
$2
|
CAGR 3-Years
37%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
EPS (Diluted)
£0
|
CAGR 3-Years
0%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
EPS (Diluted)
£0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
N4 Pharma PLC
Glance View
N4 Pharma Plc is a pharmaceutical company, which engages in the reformulation of existing drugs and vaccines. The company is headquartered in Derby, Derbyshire and currently employs 5 full-time employees. The company went IPO on 2005-06-07. The firm is engaged in engaged in the development of mesoparticulate silica delivery systems to improve the cellular delivery and potency of vaccines. The company is focused on developing a delivery system for vaccines and cancer treatments using its silica nanoparticle delivery system called Nuvec. Nuvec is a non-viral adjuvant delivery system that has the potential to revolutionize vaccines and cancer treatments. The company is focused on development and commercialization of medicines via its delivery system.
See Also
What is N4 Pharma PLC's EPS (Diluted)?
EPS (Diluted)
0
GBP
Based on the financial report for Jun 30, 2025, N4 Pharma PLC's EPS (Diluted) amounts to 0 GBP.
